Xfibra, Inc.
Del Mar, CA Business
- UEI
- D26NRF445JV3
- CAGE
- 6T6K0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 935 Jeffrey Rd, Del Mar, CA 92014, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fibronox, L.L.C. | Alpharetta, GA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Faknostics LLC | Phoenix, AZ | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Max Biopharma, Inc. | Santa Monica, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Fibrobiologics LLC | Charleston, SC | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Covenant Therapeutics LLC | Charlottesville, VA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Xfibra, Inc. Business Division, doing business as Xfibra, is a corporate entity registered as a self-certified small disadvantaged business, economically disadvantaged women-owned small business, woman-owned small business, and Native American-owned business. It appears to specialize in developing treatments for various types of fibrosis, particularly in the lungs and liver.
Xfibra has received several federal grant awards from agencies such as the Defense Health Agency, the National Institutes of Health's National Heart, Lung, and Blood Institute, and the National Institute of Diabetes and Digestive and Kidney Diseases. These grants have funded research projects focused on developing novel therapeutic treatments for pulmonary fibrosis, conducting pharmacology and toxicology studies for potential lung fibrosis treatments, and investigating treatments for liver injury and fibrosis. The grant awards range from around $1.3 million to $2.7 million in funding amounts, with project periods spanning from a few months to several years. The nature of Xfibra's work through these grants involves preclinical research and development of potential drug therapies for various types of fibrotic conditions.
Quick answers
Is Xfibra, Inc. registered in SAM.gov?
Yes. Xfibra, Inc.'s SAM.gov registration is active through March 17, 2027.
What is Xfibra, Inc.'s most recent federal award?
Xfibra, Inc.'s most recent federal grant award is A first-in-class, agnostic, host-directed precision medicine treatment for acute respiratory distress syndrome (HT94252510985), from Defense Health Agency, on September 15, 2025.
On GovTribe
See Xfibra, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors